A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A
Clinical trial NCT06916130 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06916130
- Sponsor
- Addpharma Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-21
- Primary completion
- 2025-09-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.